Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jesper Stentoft

Showing results (31-40 of 34) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 34 results.
Blood|June 21, 2011
Combination of pegylated IFN-α2b with imatinib increases molecular response rates in patients with low- or intermediate-risk chronic myeloid leukemiaBengt Simonsson, Tobias Gedde-Dahl, Berit Markevärn, et al.
Haematologica|May 20, 2017
Single cell immune profiling by mass cytometry of newly diagnosed chronic phase chronic myeloid leukemia treated with nilotinibStein-Erik Gullaksen, Jørn Skavland, Sonia Gavasso, et al.
Haematologica|October 15, 2020
Myeloproliferative and lymphoproliferative malignancies occurring in the same patient: a nationwide discovery cohortJohanne M Holst, Trine L Plesner, Martin B Pedersen, et al.
Blood Advances|September 10, 2021
Genomic profiling of a randomized trial of interferon-α vs hydroxyurea in MPN reveals mutation-specific responsesTrine Alma Knudsen, Vibe Skov, Kristen Stevenson, et al.
Pageof 4

Showing results (31-40 of 34) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 34 results.
Blood|June 21, 2011
Combination of pegylated IFN-α2b with imatinib increases molecular response rates in patients with low- or intermediate-risk chronic myeloid leukemiaBengt Simonsson, Tobias Gedde-Dahl, Berit Markevärn, et al.
Haematologica|May 20, 2017
Single cell immune profiling by mass cytometry of newly diagnosed chronic phase chronic myeloid leukemia treated with nilotinibStein-Erik Gullaksen, Jørn Skavland, Sonia Gavasso, et al.
Haematologica|October 15, 2020
Myeloproliferative and lymphoproliferative malignancies occurring in the same patient: a nationwide discovery cohortJohanne M Holst, Trine L Plesner, Martin B Pedersen, et al.
Blood Advances|September 10, 2021
Genomic profiling of a randomized trial of interferon-α vs hydroxyurea in MPN reveals mutation-specific responsesTrine Alma Knudsen, Vibe Skov, Kristen Stevenson, et al.
Pageof 4